Microsoft, Google Launch Courtroom Patent Fight Today

Photo of Paul Ausick
By Paul Ausick Published

Wikimedia Commons
The U.S. District Court in Seattle today kicks off the latest patent royalty payment battle, this one between Microsoft Corp. (NASDAQ: MSFT) and Google Inc. (NASDAQ: GOOG). The two combatants have locked horns over a reasonable royalty rate for essential patents that have become industry standards. There is no issue about the validity or enforceability of the Motorola patents now owned by Google, just over how much Google can charge to license the technology.

Microsoft filed the suit in 2010 against Motorola claiming that Moto’s proposed royalty rate of 2.25% for each Xbox and copy of Windows was not reasonable. Microsoft said that a rate that high would cost it $4 billion annually.

Motorola argues that 2.25% is the going rate and that, in any case, it was just an opening gambit in discussions with Microsoft, which apparently made a take-it-or-leave offer of about $1.2 million. Google left it, and here we are today.

A decision in the bench trial would put the first stake in the ground for what the law will say is a fair and reasonable royalty rate for essential patents. The Redmond software giant has said that it will pay whatever the judge decides is a reasonable royalty rate. Of course the losing side may appeal the judge’s decision.

Paul Ausick

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

SMCI Vol: 128,836,317
ON Vol: 12,044,310
GLW Vol: 18,574,393
MU Vol: 53,140,821
ABBV Vol: 9,912,803

Top Losing Stocks

CTRA Vol: 73,319,495
MRNA Vol: 8,363,487
PLTR Vol: 56,918,231
VRSN Vol: 1,691,263
CMG Vol: 18,457,730